Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Genetics-Supported Mainstream Testing Improves Access and Efficiency for Patients With Breast Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same author

Dynamic monitoring of antibody drug conjugates targeting TROP2 or HER2 in breast cancer using circulating tumor cells.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Safety and antitumour activity of ipatasertib combined with endocrine therapy and a CDK4/6 inhibitor in HR+/HER2- metastatic breast cancer (TAKTIC): a single-centre, open-label, phase 1b trial.

The Lancet. Oncology·2026
Same author

Author Correction: HER2 expression identifies dynamic functional states within circulating breast cancer cells.

Nature·2026
Same author

ATR Safeguards Epithelial-to-Mesenchymal Transition by Countering R-loops and Enabling Transcription Reprogramming.

The Journal of clinical investigation·2026
Same author

Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab.

Cancer discovery·2026

相关实验视频

Updated: Jun 14, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.1K

部署基于血液的癌症查

Douglas S Micalizzi1,2, Lecia V Sequist2, Daniel A Haber1,2,3

  • 1Krantz Family Center for Cancer Research, Massachusetts General Hospital Cancer Center, Harvard Medical School, Charlestown, MA, USA.

Science (New York, N.Y.)
|January 25, 2024
PubMed
概括

人工智能 (AI) 风险评估显示了个性化血液检测多种癌症的前景. 这种方法可能会导致早期癌症检测和量身定制的查策略.

科学领域:

  • 生物医学信息学
  • 癌症学
  • 基因组学

背景情况:

  • 多种癌症查旨在早期发现各种癌症.
  • 目前的查方法往往缺乏个性化,
  • 新兴技术为非侵入性癌症检测提供了新的途径.

研究的目的:

  • 探索人工智能在开发个性化风险评估模型中的潜力.
  • 评估血液查多种癌症的可行性.
  • 确定人工智能驱动的改善癌症早期检测策略.

主要方法:

  • 使用人工智能算法进行风险分层.
  • 分析大型数据集,包括基因组和临床信息.
  • 开发基于血液的生物标志物识别预测模型.

主要成果:

  • 基于人工智能的模型在评估个体癌症风险方面表现出能力.
  • 使用血液标志物进行个性化风险分析是一个可行的策略.
  • 这种方法有可能识别特定癌症的高风险个体.

结论:

  • 人工智能驱动的风险评估可以促进个性化,基于血液的多种癌症查.

更多相关视频

Real-time Cytotoxicity Assays in Human Whole Blood
08:27

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

12.2K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.9K

相关实验视频

Last Updated: Jun 14, 2026

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research
11:18

Generation of Comprehensive Thoracic Oncology Database - Tool for Translational Research

Published on: January 22, 2011

16.1K
Real-time Cytotoxicity Assays in Human Whole Blood
08:27

Real-time Cytotoxicity Assays in Human Whole Blood

Published on: November 7, 2014

12.2K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

1.9K
  • 这项技术可以显著提高早期癌症检测率.
  • 未来的研究应该集中在临床验证和AI工具在查计划中的实施上.